Stromal COX-2 signaling are correlated with colorectal cancer: A review

被引:23
|
作者
Su, Chen-Wei [1 ]
Zhang, Yuan [2 ]
Zhu, Ying-Ting [1 ]
机构
[1] TissueTech Inc, Ocular Surface Ctr, Ocular Surface Res & Educ Fdn, R&D Dept, Miami, FL USA
[2] Dalian Cent Hosp, Dalian, Liaoning Provin, Peoples R China
关键词
Cyclooxygenase-2; Prostaglandin; Proliferation; Invasion; Colorectal; Cancer; NF-KAPPA-B; COLON-CARCINOMA CELLS; PROSTAGLANDIN E-2; CONSTITUTIVE EXPRESSION; PEROXISOME PROLIFERATOR; MEDIATES PROLIFERATION; SUBTYPE EP1; CYCLOOXYGENASE-2; GROWTH; ACTIVATION;
D O I
10.1016/j.critrevonc.2016.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclooxygenase-2 (COX-2) and its product prostaglandin E-2 (PGE(2)) play a critical role in development and progression of colorectal cancer. Yet the detailed mechanistic pathways of COX-2 mediated signaling are still controversial and the role of COX-2 interaction in epithelial-stromal compartments on colorectal carcinogenesis is not well-understood either. In this review, we provide experimental evidence to support that (1) COX-2 signaling plays a major role in development and progression of colorectal cancer; (2) Stromal fibroblasts are a major source of COX-2 and PGE2; (3) Stromal-epithelial interaction mediated by COX-2 signaling promotes colorectal carcinogenesis and (4) Inhibition of stromal COX-2 signaling is necessary to control colorectal cancer. In conclusion, the evidences summarized in the review reflect recent advances and insight in mechanistic studies of colorectal cancer which can help the audiences to further understand the etiology and the control of this disease. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 50 条
  • [1] COX-2 and colorectal cancer
    Ferrández, A
    Prescott, S
    Burt, RW
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (27) : 2229 - 2251
  • [2] Stromal COX-2 signaling activated by deoxycholic acid mediates proliferation and invasiveness of colorectal epithelial cancer cells
    Zhu, Yingting
    Zhu, Min
    Lance, Peter
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 425 (03) : 607 - 612
  • [3] COX-2 inhibition and colorectal cancer
    Koehne, CH
    DuBois, RN
    SEMINARS IN ONCOLOGY, 2004, 31 (02) : 12 - 21
  • [4] COX-2 inhibitors for colorectal cancer
    Douglas J. E. Elder
    Christos Paraskeva
    Nature Medicine, 1998, 4 : 392 - 393
  • [5] COX-2 inhibitors for colorectal cancer
    Elder, DJE
    Paraskeva, C
    NATURE MEDICINE, 1998, 4 (04) : 392 - 393
  • [6] COX-2 is localized to stromal cells in human colorectal adenomas
    Adegboyega, PA
    Mifflin, RC
    Saada, JI
    Dimari, JF
    Powell, DW
    GASTROENTEROLOGY, 2001, 120 (05) : A162 - A163
  • [7] COX-2 expression and tumor angiogenesis in colorectal cancer
    Ai-Wen Wu Jin Gu Jia-Fu Ji Guang-Wei Xu Department of Surgery
    World Journal of Gastroenterology, 2004, (16) : 2323 - 2326
  • [8] The role of COX-2 in intestinal inflammation and colorectal cancer
    D Wang
    R N DuBois
    Oncogene, 2010, 29 : 781 - 788
  • [9] COX-2 INHIBITION IN THE ADJUVANT SETTING FOR COLORECTAL CANCER
    Kerr, D. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 37 - 37
  • [10] Aspirin, COX-2, and the risk of colorectal cancer - Reply
    Chan, Andrew T.
    Ogino, Shuji
    Fuchs, Charles S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08): : 824 - 825